Form 4: Aurinia Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Scott Michael Habig, Chief Commercial Officer of Aurinia Pharmaceuticals, sold 18,249 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On August 6, 2024, Scott Michael Habig, the Chief Commercial Officer of Aurinia Pharmaceuticals Inc., sold 18,249 shares of common stock.
- The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units from a grant dated August 1, 2022.
- The shares were sold at a weighted average price of $5.31, with individual transactions ranging from $5.29 to $5.34.
- Following the transaction, Habig directly owns 456,338 shares of Aurinia Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares for tax obligations) by an executive, which is neither particularly positive nor negative. It's a neutral event.
Industry Context
Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 08/01/2022 | Date of Restricted Stock Units grant related to the transaction. |
| 08/06/2024 | Date of the stock sale transaction. |
| 08/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.